The growing peril of drug-resistant superbugs

  05 February 2020

Many in India face a similar fate – they get admitted to hospitals with seemingly treatable illnesses, only to contract HAIs caused by superbugs.

While there are no India-wide estimates of how many people die due to antimicrobial resistance, Laxminarayanan pointed out that a bulk of the deaths take place in hospitals. “So, if I were to prioritise measures to tackle drug resistance, infection control in hospitals would be number one.” To be sure, HAIs have always been a risk to hospitalised patients globally. But increasing antimicrobial resistance is throwing a new spanner in the works; it is turning previously curable maladies into death sentences. The problem is that infection-control is not easy. It requires hospitals to aggressively push a range of best practices, including frequent hand washing, and caution while setting up devices like ventilators and catheters. Not enough hospitals check these boxes.

Further reading: Hindustan Times
Author(s): Priyanka Pulla
Effective Surveillance  
Back


Boosting innovation in AMR?

15 OCT 2020: online Kick Off event AMR Innovation Mission UK 2021

 

The AMR Innovation Mission UK 2020/2021 aims to add to the global curbing of AMR by boosting joint early & translational research, R&D, clinical development,  validation, registration and commercialisation of vaccines, microbial diagnostics and antimicrobial products.

 

Register today >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!